Indaptus Therapeutics Inc
Biotechnology
Healthcare
INDP
8.40 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
1.80
52 week high
3.95
high
1.84
52 week low
1.37
low
1.70
growth
7.98 %
previous Close
1.76
P/E ratio
market cap
24.70 M
div yield
0
usd
Sep 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top